Anabel Zwick
Homburg, SL, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotype.
Journal: Oral oncology
Published: July 31, 2024
The impact of the tumor microenvironment on the survival of penile cancer patients.
Journal: Scientific reports
Published: May 10, 2024
Engineering Dimeric EGFR-directed IgA Antibodies Reveals a Central Role of CD147 during Neutrophil-mediated Tumor Cell Killing of Head and Neck Squamous Cancer Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 11, 2023
The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer.
Journal: Frontiers in oncology
Published: March 07, 2022
DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells.
Journal: Translational oncology
Published: September 15, 2021
German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance.
Journal: Communications medicine
Published: May 05, 2021
The HPV and p63 Status in Penile Cancer Are Linked with the Infiltration and Therapeutic Availability of Neutrophils.
Journal: Molecular cancer therapeutics
Published: March 06, 2020
Optimized Xenograft Protocol for Chronic Lymphocytic Leukemia Results in High Engraftment Efficiency for All CLL Subgroups.
Journal: International journal of molecular sciences
Published: November 21, 2019
PIM1 inhibition effectively enhances plerixafor-induced HSC mobilization by counteracting CXCR4 upregulation and blocking CXCL12 secretion.
Journal: Leukemia
Published: January 30, 2019
Monitoring kinetics reveals critical parameters of IgA-dependent granulocyte-mediated anti-tumor cell cytotoxicity.
Journal: Journal of immunological methods
Published: January 17, 2019
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes.
Journal: Oncotarget
Published: April 04, 2017
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers.
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers.
Journal: Clinical epigenetics
Published: March 04, 2016
Last Updated: 09/26/2026